rs144755516
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000006750.8(CD79B):c.179C>T(p.Thr60Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000211 in 1,614,104 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
ENST00000006750.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD79B | NM_000626.4 | c.179C>T | p.Thr60Met | missense_variant | 3/6 | ENST00000006750.8 | NP_000617.1 | |
CD79B | NM_001039933.3 | c.182C>T | p.Thr61Met | missense_variant | 3/6 | NP_001035022.1 | ||
CD79B | NM_001329050.2 | c.122-437C>T | intron_variant | NP_001315979.1 | ||||
CD79B | NM_021602.4 | c.119-437C>T | intron_variant | NP_067613.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD79B | ENST00000006750.8 | c.179C>T | p.Thr60Met | missense_variant | 3/6 | 1 | NM_000626.4 | ENSP00000006750 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152216Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251114Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135768
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1461770Hom.: 0 Cov.: 34 AF XY: 0.0000220 AC XY: 16AN XY: 727192
GnomAD4 genome AF: 0.0000656 AC: 10AN: 152334Hom.: 0 Cov.: 33 AF XY: 0.0000671 AC XY: 5AN XY: 74478
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Apr 10, 2020 | - - |
Agammaglobulinemia 6, autosomal recessive Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 05, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The methionine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 133839). This variant has not been reported in the literature in individuals affected with CD79B-related conditions. This variant is present in population databases (rs144755516, gnomAD 0.02%). This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 60 of the CD79B protein (p.Thr60Met). - |
not specified Other:1
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at